It was shown that SEPHS2 was elevated in breast tumor samples, and its overexpression was correlated with advanced tumor grade, suggesting that SEPHS2 may serve as a prognostic marker and therapeutic target for patients with breast cancer (55). Here, SEPHS2 is linked to breast carcinoma.